Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $684.07 million. The enterprise value is $430.48 million.
| Market Cap | 684.07M |
| Enterprise Value | 430.48M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLO has 345.49 million shares outstanding. The number of shares has increased by 19.14% in one year.
| Current Share Class | 345.49M |
| Shares Outstanding | 345.49M |
| Shares Change (YoY) | +19.14% |
| Shares Change (QoQ) | +36.89% |
| Owned by Insiders (%) | 5.75% |
| Owned by Institutions (%) | 74.81% |
| Float | 262.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 147.43 |
| Forward PS | 57,006.00 |
| PB Ratio | 1.57 |
| P/TBV Ratio | 1.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 92.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.72, with a Debt / Equity ratio of 0.18.
| Current Ratio | 10.72 |
| Quick Ratio | 10.55 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -138.71 |
Financial Efficiency
Return on equity (ROE) is -42.39% and return on invested capital (ROIC) is -23.81%.
| Return on Equity (ROE) | -42.39% |
| Return on Assets (ROA) | -22.08% |
| Return on Invested Capital (ROIC) | -23.81% |
| Return on Capital Employed (ROCE) | -34.79% |
| Weighted Average Cost of Capital (WACC) | 6.24% |
| Revenue Per Employee | $30,526 |
| Profits Per Employee | -$1.09M |
| Employee Count | 152 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +75.22% in the last 52 weeks. The beta is 0.47, so ALLO's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +75.22% |
| 50-Day Moving Average | 1.99 |
| 200-Day Moving Average | 1.96 |
| Relative Strength Index (RSI) | 47.69 |
| Average Volume (20 Days) | 4,798,189 |
Short Selling Information
The latest short interest is 58.95 million, so 17.06% of the outstanding shares have been sold short.
| Short Interest | 58.95M |
| Short Previous Month | 60.75M |
| Short % of Shares Out | 17.06% |
| Short % of Float | 22.46% |
| Short Ratio (days to cover) | 10.07 |
Income Statement
In the last 12 months, ALLO had revenue of $4.64 million and -$165.49 million in losses. Loss per share was -$0.65.
| Revenue | 4.64M |
| Gross Profit | -117.88M |
| Operating Income | -180.32M |
| Pretax Income | -165.49M |
| Net Income | -165.49M |
| EBITDA | -168.65M |
| EBIT | -180.32M |
| Loss Per Share | -$0.65 |
Balance Sheet
The company has $332.60 million in cash and $79.01 million in debt, with a net cash position of $253.60 million or $0.73 per share.
| Cash & Cash Equivalents | 332.60M |
| Total Debt | 79.01M |
| Net Cash | 253.60M |
| Net Cash Per Share | $0.73 |
| Equity (Book Value) | 436.18M |
| Book Value Per Share | 1.26 |
| Working Capital | 308.27M |
Cash Flow
In the last 12 months, operating cash flow was -$102.20 million and capital expenditures -$402,000, giving a free cash flow of -$102.60 million.
| Operating Cash Flow | -102.20M |
| Capital Expenditures | -402,000 |
| Depreciation & Amortization | 11.67M |
| Net Borrowing | n/a |
| Free Cash Flow | -102.60M |
| FCF Per Share | -$0.30 |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,886.14% |
| Pretax Margin | -3,566.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.14% |
| Shareholder Yield | -19.14% |
| Earnings Yield | -24.19% |
| FCF Yield | -15.00% |
Analyst Forecast
The average price target for ALLO is $9.00, which is 354.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 354.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALLO has an Altman Z-Score of -3.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.46 |
| Piotroski F-Score | 2 |